A live attenuated zoster vaccine for the prevention of shingles has been licensed for older adults in the US since 2006. How effective has it been over the long-term, and does efficacy differ by age?
American Journal of Epidemiology
Original Article: Long-term Effectiveness of the Live Zoster Vaccine
NEXT ARTICLE